| scholarly article | Q13442814 |
| P50 | author | Lois B. Travis | Q91794501 |
| P2093 | author name string | Huilin Li | |
| Louis S Constine | |||
| Michael T Milano | |||
| P2860 | cites work | Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk | Q24245375 |
| Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood | Q28143725 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. | Q33801101 | ||
| Treatment of locally advanced non-small cell lung cancer: what we have and have not learned over the past decade | Q36193531 | ||
| Lung cancer after treatment for Hodgkin's lymphoma: a systematic review | Q36274388 | ||
| Advances in chemotherapy of non-small cell lung cancer | Q36621151 | ||
| Second cancer risk following Hodgkin's disease: a 20-year follow-up study | Q36742889 | ||
| Hodgkin lymphoma: the follow-up of long-term survivors | Q37131517 | ||
| Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cance | Q37423919 | ||
| Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients | Q38438181 | ||
| Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease | Q38463563 | ||
| Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment | Q39501899 | ||
| Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma: smaller volumes and higher doses--a review | Q41695118 | ||
| Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment | Q43543604 | ||
| Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger | Q43673371 | ||
| The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials | Q43720688 | ||
| Lung cancer after treatment for Hodgkin's disease: focus on radiation effects | Q43853157 | ||
| Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease | Q43878525 | ||
| Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. | Q44616496 | ||
| Lung cancer after treatment for non-Hodgkin lymphoma. | Q44909437 | ||
| Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease | Q45074869 | ||
| The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition | Q45837881 | ||
| Clinical course of thoracic cancers in Hodgkin's disease survivors. | Q47822688 | ||
| Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. | Q53460488 | ||
| Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome | Q57643868 | ||
| Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years | Q58411329 | ||
| The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease | Q59566170 | ||
| Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials | Q62096584 | ||
| The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy | Q70332562 | ||
| Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation | Q71572014 | ||
| Lung cancer after Hodgkin's disease | Q72019222 | ||
| Long-term cause-specific mortality of patients treated for Hodgkin's disease | Q73718801 | ||
| Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors | Q74675998 | ||
| Lung cancer after Hodgkin lymphoma: the roles of chemotherapy, radiotherapy and tobacco use | Q80934771 | ||
| P433 | issue | 1 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 22-29 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Journal of thoracic disease | Q26841814 |
| P1476 | title | Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients | |
| P478 | volume | 4 |
| Q38022455 | Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma |
| Q35650402 | Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications |
| Q94585802 | Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study |
| Q41153190 | Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma |
| Q90612100 | Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study) |
Search more.